AGA guideline endorses fecal microbiota transplant as treatm

In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends fecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

Related Keywords

United States , American , Amanda Kabage , Anne Peery , American Gastroenterological Association , C Diff , Transplant , Colon , Fecal Microbiota Transplantation , Astroenterology , Gastrointestinal Disease , Icrobiome , Research ,